There is a lack of coordination and collaboration between investigators working to combat nontuberculous mycobacteria infections. NHLBI could provide incentives for research leadership on NTM issues.
2. Combination therapy vs monotherapy for pneumonia due to Pseudomonas. This is another major area of contention – for nearly 2 decades, and generates... more »